Cashu
Halper Sadeh probes Lisata Therapeutics' cash‑plus‑CVR sale over fiduciary and disclosure concerns
28 days ago
Stocks
Health Care
lsta
Lisata Therapeutics
NASDAQ: LSTA
-0.00 (-0.10%)
5.025
USD
At close at Mar 13, 20:39 UTC
Overview
Loading chart...
Key Stats
Market Cap
44.04M
Dividend Yield
0.00%
P/E Ratio
-2.41
EPS
-2.40
Revenue
1.00M
Avg. Volume
178.86K
About
What does LSTA do?
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.